Live Breaking News & Updates on Drug Development Of Medicines

Das Tübinger Start-up Unternehmen HepaRegeniX hat vor kurzem mit der klinischen Phase I Studie begonnen, um die Verträglichkeit eines neuartigen Medikamentes gegen Lebererkrankungen an gesunden Pr . ....

Awarda Excellence University , Drug Development Of Medicines , Drug Development , University Hospital , Research Group , Research Cooperation , University Tbingen , University Hospital Tbingen , Liver Disease , Medication With , Preclinical Studies , Drug Effects , Slarge Percentage , Medical Director , Medical Oncology , Instantaneous Water , Medical Chemistry , Cause Of Death , Million People , Overweight Or Alcohol , Fat Liver , Death Cases An Year , Application People , Study Start , Working Group , Excellence University ,